Securities code: 688013 securities abbreviation: Touchstone International Medical Science Co.Ltd(688013) Announcement No.: 2022-002 Touchstone International Medical Science Co.Ltd(688013)
Announcement on the proposal of the chairman, controlling shareholder and one of the actual controllers of the company to repurchase shares
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law. Important content tips:
The board of directors of Touchstone International Medical Science Co.Ltd(688013) (hereinafter referred to as “the company”) received the letter on proposing Touchstone International Medical Science Co.Ltd(688013) repurchase of shares of the company from Mr. Chen Wangyu, chairman of the board of directors, controlling shareholder and one of the actual controllers of the company, on February 3, 2022. Mr. Chen Wangyu proposed that the company buy back some RMB common shares (A shares) issued by the company through the trading system of Shanghai stock exchange with its own funds through centralized bidding trading.
1、 Basic information of the proposer and time of proposal
1. Proposer: Mr. Chen Wangyu, chairman, controlling shareholder and one of the actual controllers of the company.
2. Proposed date: February 3, 2022.
2、 Reasons and purposes of the proposer’s proposal to repurchase shares
Based on his confidence in the company’s future development and recognition of the company’s value, Mr. Chen Wangyu, chairman, controlling shareholder and one of the actual controllers of the company, in order to establish and improve the company’s long-term incentive mechanism, fully mobilize the enthusiasm of the company’s employees, effectively combine the interests of shareholders, the company and employees’ personal interests, and promote the healthy and sustainable development of the company, It is proposed that the company buy back some shares with its own funds and use the repurchased shares for employee stock ownership plan or equity incentive.
3、 Content of the proposer’s proposal
1. Types of repurchased shares: RMB ordinary shares (A shares) issued by the company;
2. Purpose of Share Repurchase: for employee stock ownership plan or equity incentive;
3. The way of Share Repurchase: through the trading system of Shanghai Stock Exchange, the shares are repurchased by means of centralized bidding transaction;
4. Price of repurchased shares: no more than RMB 23.00/share (inclusive);
5. Total amount of share repurchase funds: the total amount of share repurchase funds shall not be less than 50 million yuan (inclusive) and not more than 100 million yuan (inclusive);
6. The number of shares repurchased and its proportion in the total share capital of the company: the number of shares repurchased is calculated according to the maximum repurchase amount of RMB 100 million and the maximum repurchase price of RMB 23.00/share. The number of shares repurchased is about 4347826, and the proportion of shares repurchased accounts for about 5.43% of the total share capital of the company. According to the calculation of the lower limit of 50 million yuan and the upper limit of 23.00 yuan / share, the number of repurchases is about 2173913 shares, accounting for about 2.72% of the total share capital of the company.
4、 The situation of the proposer’s purchase and sale of the company’s shares within 6 months before the proposal
The proposer, Mr. Chen Wangyu, did not buy or sell shares of the company within 6 months before the proposal.
5、 Increase or decrease plan of the proposer during the repurchase period
The proposer, Mr. Chen Wangyu, has no plan to increase or decrease his holdings during the repurchase period.
6、 Proposer’s commitment
The proposer, Mr. Chen Wangyu, promised that he would actively promote the company to convene the board of directors as soon as possible to consider the share repurchase, and would vote in favor of the company’s share repurchase proposal at the board of directors.
7、 Opinions of the board of directors on the share repurchase proposal and subsequent arrangements
On February 8, 2022, the 19th meeting of the first board of directors of the company deliberated and adopted the proposal on repurchase of shares of the company by means of centralized bidding transaction. All directors of the company attended the meeting and adopted the proposal with 7 votes in favor, 0 abstention, 0 opposition and 0 avoidance. The independent directors expressed their independent opinions on this matter, At the same time, the management of the company is authorized to handle the matters related to the share repurchase. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) disclosed by the company on the same day Announcement of Touchstone International Medical Science Co.Ltd(688013) on the scheme of repurchasing shares of the company by means of centralized bidding transaction (Announcement No.: 2022-004).
It is hereby announced.
Touchstone International Medical Science Co.Ltd(688013) board of directors February 9, 2022
